Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: Clin Cancer Res. 2020 Aug 5;27(1):15–23. doi: 10.1158/1078-0432.CCR-20-1395

Fig. 3.

Fig. 3.

The multiple myeloma mutational signature landscape. a) The prevalence and median of somatic mutations across human cancer types evaluated by WGS. b) The nine mutational signatures extracted from WGS data in multiple myeloma.